V1 sact_regimen
730,471 rows · 12 columns
| MERGED_REGIMEN_ID | MERGED_TUMOUR_ID | HEIGHT_AT_START_OF_REGIMEN | WEIGHT_AT_START_OF_REGIMEN | INTENT_OF_TREATMENT | DATE_DECISION_TO_TREAT | START_DATE_OF_REGIMEN | MAPPED_REGIMEN | CLINICAL_TRIAL | CHEMO_RADIATION | MERGED_PATIENT_ID | BENCHMARK_GROUP |
|---|---|---|---|---|---|---|---|---|---|---|---|
| 330010468 | 330008751 | 1.59 | 56.7 | Palliative (P) | 2015-09-06 | 2015-09-10 | CISPLATIN + ETOPOSIDE | 2 | null | 330016088 | NIVOLUMAB |
| 330010469 | 330010741 | 1.7 | 22.55 | Palliative (P) | 2014-10-18 | 2014-10-18 | Docetaxel 75mg/m2 (21 day) | N | N | 330016125 | DOCETAXEL |
| 330010470 | 330012484 | 1.77 | 76.4 | Curative (C) | 2015-08-08 | 2015-08-09 | Azacitidine | null | N | 330016135 | DA |
| 330010471 | 330005037 | 0 | 22.2 | null | 2018-11-14 | 2018-11-29 | Trabectedin | N | N | 330016168 | TRABECTEDIN |
| 330010472 | 330005042 | 1.71 | null | Curative (C) | null | 2017-01-12 | CNS Low Grade Glioma Vinblastine | 02 | N | 330016204 | CAV |
| 330010473 | 330005047 | 1.8 | 68.4 | Palliative (P) | 2015-01-28 | 2015-02-04 | Etoposide oral | N | N | 330016224 | ETOPOSIDE |
| 330010474 | 330012837 | 0.95 | 48.8 | Neo-adjuvant (N) | 2016-10-09 | 2016-10-13 | Cyclophosphamide + Topotecan | null | null | 330016234 | VINBLASTINE |
| 330010475 | 330008758 | 1.6 | 79.3 | Adjuvant (A) | null | 2016-12-09 | Cyclophosphamide + Topotecan | 02 | N | 330016238 | CYCLOPHOSPHAMIDE + TOPOTECAN |
| 330010476 | 330005052 | 1.48 | 69 | Curative (C) | 2015-10-14 | 2015-10-14 | Vinblastine | N | N | 330016242 | VINBLASTINE |
| 330010477 | 330005053 | 1.67 | 72.4 | Curative (C) | 2014-11-13 | 2014-11-14 | EURO-EWING | N | N | 330016249 | EURO-EWING |
| 330010478 | 330005053 | null | 35.5 | Neo-adjuvant (N) | 2014-05-02 | 2014-07-18 | EURO-EWING | N | N | 330016249 | EURO-EWING |
| 330010479 | 330012838 | 1.67 | null | Palliative (P) | 2017-08-31 | 2017-09-01 | NIVOLUMAB | N | N | 330016265 | NIVOLUMAB |
| 330010480 | 330008762 | 1.6 | 64.7 | Palliative (P) | 2017-08-22 | 2017-09-19 | Irinotecan + Temozolomide | N | null | 330016269 | IRINOTECAN + TEMOZOLOMIDE |
| 330010481 | 330005056 | null | 31.3 | Curative (C) | 2016-07-26 | 2016-08-02 | EURO-EWING | null | null | 330016281 | EURO-EWING |
| 330010482 | 330005056 | 1.61 | 48 | Disease modification (D) | 2013-10-31 | 2013-11-28 | Methotrexate intrathecal | 02 | N | 330016281 | METHOTREXATE INTRATHECAL |
| 330010483 | 330005058 | 1.65 | 74 | Palliative (P) | 2014-07-23 | 2014-08-17 | Liposomal Doxorubicin (Caelyx) | N | N | 330016327 | LIPOSOMAL DOXORUBICIN |
| 330010484 | 330005060 | 1.75 | 81.4 | Curative (C) | 2016-06-19 | 2016-09-13 | Methotrexate intrathecal | N | N | 330016340 | METHOTREXATE INTRATHECAL |
| 330010485 | 330005063 | null | 63 | Palliative (P) | 2017-10-29 | 2017-10-29 | Trabectedin | N | N | 330016404 | TRABECTEDIN |
| 330010486 | 330005065 | 1.52 | 64.1 | Palliative (P) | 2016-09-13 | 2016-09-21 | Cyclophosphamide + Topotecan | N | N | 330016407 | CYCLOPHOSPHAMIDE + RITUXIMAB |
| 330010487 | 330005069 | 1.75 | 14.9 | Palliative (P) | 2017-10-28 | 2017-10-28 | Temozolomide 200mg/m2 | N | N | 330016460 | DA |
| 330010488 | 330005069 | 1.69 | 67.2 | Neo-adjuvant (N) | 2015-05-03 | 2015-05-03 | CNS Low Grade Glioma Vinblastine | 02 | null | 330016460 | CISPLATIN + DOXORUBICIN |
| 330010489 | 330005069 | 1.84 | 57.5 | Palliative (P) | 2015-02-09 | 2015-02-13 | Cyclophosphamide + Topotecan | N | null | 330016460 | CYCLOPHOSPHAMIDE + RITUXIMAB |
| 330010490 | 330008771 | 1.58 | 11.5 | Palliative (P) | 2015-03-15 | 2015-03-19 | Irinotecan + Temozolomide | N | N | 330016503 | IRINOTECAN + TEMOZOLOMIDE |
| 330010491 | 330008772 | 1.7 | 67.7 | Palliative (P) | null | 2014-10-16 | Vinblastine | N | N | 330016514 | AZACITIDINE |
| 330010492 | 330005074 | 1.51 | null | Curative (C) | 2018-10-12 | 2018-10-16 | FLAG + Idarubicin | N | N | 330016543 | FLAG + IDARUBICIN |
| 330010493 | 330005076 | 1.68 | 91.6 | Palliative (P) | null | 2018-06-21 | Vinblastine | null | Y | 330016578 | NIVOLUMAB |
| 330010494 | 330005076 | null | 80.5 | Neo-adjuvant (N) | 2013-05-31 | 2014-01-31 | Liposomal Doxorubicin (Caelyx) | N | N | 330016578 | LIPOSOMAL DOXORUBICIN |
| 330010495 | 330005077 | 1.76 | 73 | Palliative (P) | 2017-08-06 | 2017-08-27 | Azacitidine | N | N | 330016585 | CYCLOPHOSPHAMIDE + TOPOTECAN |
| 330010496 | 330008777 | 0 | 86.4 | Disease modification (D) | 2018-03-20 | 2018-03-20 | Etoposide oral | 02 | N | 330016588 | ETOPOSIDE |
| 330010497 | 330005082 | 1.31 | 67.8 | Curative (C) | 2017-09-27 | 2017-10-12 | FLAG + Idarubicin | N | N | 330016591 | FLAG + IDARUBICIN |
| 330010498 | 330011861 | 1.83 | 70.6 | Curative (C) | 2015-12-30 | 2016-01-06 | CAV | N | N | 330016615 | CISPLATIN + ETOPOSIDE |
| 330010499 | 330005084 | 1.9 | 71.65 | Palliative (P) | 2015-05-03 | 2015-11-24 | Docetaxel 75mg/m2 (21 day) | N | N | 330016630 | DOCETAXEL |
| 330010500 | 330005085 | 1.6 | null | Curative (C) | 2017-06-20 | 2017-06-20 | VAC | 02 | N | 330016666 | CISPLATIN + DOXORUBICIN |
| 330010501 | 330008781 | null | 76.5 | Curative (C) | 2016-07-23 | 2016-07-25 | Methotrexate intrathecal | 02 | null | 330016671 | METHOTREXATE INTRATHECAL |
| 330010502 | 330008781 | 1.5 | 0 | Curative (C) | 2016-06-21 | 2016-06-25 | Cisplatin + Doxorubicin | null | N | 330016671 | TEMOZOLOMIDE |
| 330010503 | 330005087 | 1.8 | 82.8 | Palliative (P) | null | 2017-03-03 | Cyclophosphamide + Topotecan | 02 | N | 330016697 | CYCLOPHOSPHAMIDE + TOPOTECAN |
| 330010506 | 330005093 | 1.78 | 59.2 | Palliative (P) | 2017-12-09 | 2017-12-09 | GEMCARBO | N | N | 330016728 | GEMCARBO |
| 330010507 | 330005095 | 1.62 | 15.1 | Radical (R) | 2017-01-31 | 2017-03-01 | Cyclophosphamide + Topotecan | N | N | 330016730 | CAV |
| 330010508 | 330005097 | 1.73 | 69.7 | Curative (C) | 2018-03-30 | 2018-06-30 | NIVOLUMAB | 02 | N | 330016751 | NIVOLUMAB |
| 330010509 | 330008785 | 1.67 | 61.4 | Palliative (P) | 2017-07-31 | 2017-08-08 | NIVOLUMAB | 02 | N | 330016751 | NIVOLUMAB |
| 330010510 | 330008786 | 1.75 | 77.3 | Disease modification (D) | 2016-01-17 | 2016-01-31 | Liposomal Doxorubicin (Caelyx) | 02 | Y | 330016781 | LIPOSOMAL DOXORUBICIN |
| 330010511 | 330005100 | 1.66 | 114.6 | Curative (C) | 2014-10-30 | 2016-06-20 | Methotrexate intrathecal | Y | N | 330016821 | METHOTREXATE INTRATHECAL |
| 330010512 | 330005102 | 1.77 | 61 | Palliative (P) | 2017-07-04 | 2017-07-24 | Trabectedin | N | N | 330016822 | TRABECTEDIN |
| 330010513 | 330008788 | 1.8 | 47.8 | Curative (C) | 2014-02-04 | 2014-02-25 | Methotrexate intrathecal | N | N | 330016828 | METHOTREXATE INTRATHECAL |
| 330010514 | 330005105 | 1.58 | null | Disease modification (D) | 2016-07-06 | 2016-07-07 | ETOPOSIDE | 2 | N | 330016830 | ETOPOSIDE |
| 330010515 | 330005107 | 1.7 | 62.3 | Disease modification (D) | 2014-07-07 | 2014-07-08 | Vinblastine | N | N | 330016918 | NIVOLUMAB |
| 330010516 | 330008792 | 1.87 | 51.2 | Curative (C) | 2017-07-28 | 2017-09-08 | Methotrexate intrathecal | N | N | 330016923 | METHOTREXATE INTRATHECAL |
| 330010517 | 330005113 | 0 | 15.9 | Neo-adjuvant (N) | 2013-11-29 | 2013-12-12 | Cyclophosphamide + Topotecan | Y | N | 330016960 | CISPLATIN + DOXORUBICIN |
| 330010518 | 330005117 | 1.03 | 82.2 | Palliative (P) | 2016-10-25 | 2016-10-26 | Azacitidine | 02 | N | 330016967 | NIVOLUMAB |
| 330010519 | 330008798 | 0 | null | Palliative (P) | 2013-06-01 | 2013-09-15 | Docetaxel 75mg/m2 (21 day) | N | N | 330016972 | DOCETAXEL |